MedTrace Logo

Micronutrient Supplementation in Patients With Heart Failure

NCT01005303 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2023-12-01

Study results available
· View outcomes & findings →

Summary

There is some evidence to suggest that patients with heart failure may have a reduced dietary intake of vitamins and essential minerals (micronutrients) and that this may worsen the function of the heart. This study is designed to investigate if supplementation with micronutrients (including high-dose vitamin D) will improve the function of the heart in patients with heart failure.

Conditions

Interventions

DRUG

Placebo

1 Tablet Daily

DRUG

Forceval plus 50 micrograms Vitamin D3

Forceval: 1 Tablet Daily; Vitamin D3: 2 Tablets Daily

Sponsors & Collaborators

  • Belfast Health and Social Care Trust

    lead OTHER

Principal Investigators

  • Pascal McKeown, MD · Belfast Health and Social Care Trust

  • Mark Harbinson, MD · Belfast Health and Socail Care Trust

  • Michelle McKinley, PhD · The Queen's Univeristy of Belfast

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2013-08-31
Completion
2015-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01005303 on ClinicalTrials.gov